Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Livzon Pharmaceutical Group ( (HK:1513) ) has provided an announcement.
Livzon Pharmaceutical Group Inc. has announced a board meeting scheduled for April 23, 2025, to review and approve the company’s unaudited quarterly results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting stakeholders and market positioning.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is based in Zhuhai, China, and is involved in providing a range of healthcare solutions.
YTD Price Performance: -4.93%
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.1B
For a thorough assessment of 1513 stock, go to TipRanks’ Stock Analysis page.